Table 4.
Repeated measures general linear model (GLM).
| - | OAPs | Aripiprazole | Aripiprazole LAI | Brexpiprazole | F | p |
|---|---|---|---|---|---|---|
| CGI-S | 4.68 | 4.75 | 4.38 | 4.36 | 4.87 | 0.003 |
| BIS-11 Total | 82.26 | 83.25 | 81.36 | 82.61 | 0.10 | 0.961 |
| BPRS | 63.77 | 70.71 | 56.27 | 61.71 | 3.10 | 0.031 |
| PANSS Total | 91.45 | 91.00 | 79.70 | 85.50 | 2.60 | 0.057 |
| PANSS Negative | 25.00 | 22.19 | 20.84 | 22.04 | 3.10 | 0.031 |
| PANSS Positive | 19.26 | 21.81 | 18.42 | 18.50 | 0.715 | 0.546 |
| PANSS General Psychopathology | 47.36 | 47.00 | 40.42 | 44.79 | 3.53 | 0.018 |
| VAScrav frequency | 5.83 | 6.44 | 4.58 | 5.29 | 3.89 | 0.012 |
| VAScrav intensity | 6.78 | 7.38 | 5.61 | 5.79 | 4.87 | 0.004 |
Abbreviations: BIS-11, Barratt Impulsiveness Scale; BPRS, 24-item Brief Psychiatric Rating Scale; CGI-S, Clinical Global Impressions scale, Severity; OAPs, other antipsychotics; PANSS, Positive And Negative Syndrome Scale; VAScrav, visual analogue scale for craving. Note: Significance in bold.